NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002289

Registered date:03/08/2009

Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedcirrhotic patients who underwent laparoscopic splenectomy
Date of first enrollment2006/01/01
Target sample size25
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Cirrhotic patients who underwent laparoscopic splenectomy received an intravenous infusion of 1,500 units of AT-III concentrates over approximately 1 hour on post-operative day 1, 2, and 3.

Outcome(s)

Primary OutcomeComparison of the incidence of portal vein thrombosis between cirrhotic patients with or without AT-III concentrates
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Patients who had portal vein thrombosis before the operation. 2. Patients who had post-operative bleeding requiring hemostasis.

Related Information

Contact

public contact
Name Hirofumi Kawanaka
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan Japan
Telephone 092-642-5466
E-mail harrykawa2002@yahoo.co.jp
Affiliation Kyushu University Hospital Department of Surgery and Science
scientific contact
Name Hirofumi Kawanaka
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan Japan
Telephone 092-642-5466
E-mail
Affiliation Kyushu University Hospital Department of Surgery and Science